Management of obsessive compulsive disorder

Psychotherapy and Psychosomatics

Volumn 73, Issue 3, 2004, Pages 149-157

  Bouvard, Martine A ^a,b   Milliery, Maud ^a   Cottraux, Jean ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b UNIVERSITÉ DE SAVOIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; PAROXETINE; PLACEBO; RISPERIDONE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY DISORDER; BEHAVIOR THERAPY; CHILD HEALTH; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; COMORBIDITY; COMPULSION; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GENERALIZED ANXIETY DISORDER; GROUP THERAPY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOTHERAPY; RATING SCALE; REVIEW; SCHIZOTYPAL PERSONALITY DISORDER; SIDE EFFECT; TIC; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; ALGORITHMS; CASE MANAGEMENT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 1842560489     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076452     Document Type: Review

References (56)

1. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Brown MA, Robino-Stipec M, Wickramaratne PJ, Wittchen HU, Yeh EK: The Cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry 1994;55(suppl 3):3-10.
2. Williams KE, Koran LN: Obsessive compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 1997;58:330-334.
3. Maina G, Albert U, Bogetto F, Vaschetto P, Ravizza L: Recent life events and obsessive compulsive disorder (OCD): The role of pregnancy/delivery. Psychiatry Res 1999;89:49-58.
4. Buttolph ML, Peets KE, Holland AD: Obsessive-compulsive disorder: Symptoms and medication, treatment in pregnancy; in Jenike MA, Baer L, Minichiello WE (eds): Obsessive-Compulsive Disorder: Practical Management. St. Louis, Mosby, 1998.
5. Hollander E, Greenwald S, Neville D, Johnson J, Hornig CD: Uncomplicated and comorbid obsessive compulsive disorder in epidemiological sample. Depress Anxiety 1996;4:111-119.
6. Sasson Y, Zohar J, Chopra M, Lusting M, Iancu I, Hendler T: Epidemiology of OCD: A world view. J Clin Psychiatry 1997;58(suppl 12):7-10.
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994. Traduction française: Guelfi GD, Boyer P, Pull CB, Pull MC: Manuel diagnostique et statistique des troubles mentaux. Paris, Masson, 1996.
8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994. Traduction française: Guelfi GD, Boyer P, Pull CB, Pull MC: Manuel diagnostique et statistique des troubles mentaux. Paris, Masson, 1996.
9. Foa EB, Franklin ME, Kozak MJ: Psychosocial treatments of obsessive-compulsive disorder: A literature review; in Swinson RP, Anthony MM, Rachman S, Richter MA (eds): Obsessive-Compulsive Disorder: Theory, Research and Treatment. New York, Guilford, 1998.
10. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush IA, Domingez RA, Koran L, Shear KM, Goodman W, Genduso LA: A multi-center investigation of fixed dose fluoxetine in the treatment of obsessive compulsive disorder. Arch Gen Psychiatry 1994;51:559-567.
11. Van Balkom AJLM, Van Oppen P, Vermeulen AWA, Van Dyck R, Nauta MCE, Vorst HCM: A meta-analysis on the treatment of obsessive compulsive disorder: A comparison of antidepressants, behaviour and cognitive therapy. Clin Psychol Rev 1994;14:359-381.
12. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ: Behavioural versus pharmacological treatments of obsessive compulsive disorder. Psychopharmacology 1998;3:205-216.
13. Marks I: Fear, Phobias and Rituals. New York, Oxford University Press, 1987.
14. Foa E, Wilson R: Stop Obsessing. How to Overcome Obsessions and Compulsions. New York, Bantam Books, 1991.
15. Rachman SJ, De Silva P: Abnormal and normal obsessions. Behav Res Ther 1978;16:233-248.
16. Salkovskis PM: Cognitive behavioural factors and the persistence of intrusive thoughts in obsessional problems. Behav Res Ther 1989;27:677-682.
17. Beck AT: Cognitive Therapy and the Emotional Disorders. New York, International University Press, 1976.
18. van Oppen P, De Haan E, Van Balkom AJLM, Spinhoven P, Hoogduin K, Van Dyck R: Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther 1995;33:379-390.
19. Cottraux J, Note I, Yao SN, Lafont S, Note B, Mollard E, Bouvard M, Sauteraud A, Bourgeois M, Dartigues JF: A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom 2001;70:288-297.
20. Goodman WK: Obsessive-compulsive disorder: Diagnosis and treatment. J Clin Psychiatry 1999;60(suppl 8):27-32.
21. Mundo E, Bianchi L, Bellodi L: Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: A single bind study. J Clin Psychopharmacol 1997;17:267-271.
22. Flament MF, Bisserbe JC: Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. J Clin Psychiatry 1997;58(suppl 12):18-22.
23. Koran LM, McElroy SL, Davidson JRT, Rasmussen SA, Hollander E, Jenike MA: Fluvoxamine versus clomipramine for obsessive compulsive disorder: A double-blind comparison. J Clin Psychopharmacol 1996;16:121-129.
24. Lopez-Ibor JJ, Saiz J, Cottraux J, Note I, Vinas R, Bourgeois M, Hernandez M, Gomez-Perez JC: Double-bind comparison of fluoxetine versus clomipramine in the treatment of OCD. Eur Neuropsychopharmacol 1996;6:111-118.
25. Mundo E, Maina G, Uslenghi C: Multicentre, double-blind comparison of fluvoxamine and clomipramine in the treatment of obsessivecompulsive disorder. Int Clin Psychopharmacol 2000;15:69-76.
26. Bisserbe JC, Lane RM, Flament MF, the Franco-Belgian OCD Study Group: A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder. Eur Psychiatry 1997;12:82-93.
27. Zohar J, Judge R, the OCD Paroxetine Study Investigators: Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br J Psychiatry 1996;169:468-474.
28. Freeman CPL, Trimble MR, Deakin JFW, Stokes TM, Ashford JJ: Fluvoxamine versus clomipramine in the treatment of obsessivecompulsive disorder: A multicenter, randomized, double-bind, parallel group comparison. J Clin Psychiatry 1994;55:301-305.
29. Jenike MA, Baer L, Greist JH: Clomipramine versus fluoxetine in obsessive-compulsive disorder: A retrospective comparison of side effects and efficacy. J Clin Psychopharmacol 1990;10:122-124.
30. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL: Controlled comparison of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1990;47:926-932.
31. Pigott TA, Seay SM: A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 1999;60:101-106.
32. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC: Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis. Arch Gen Psychiatry 1995;52:53-60.
33. Stein DJ, Spadaccini E, Hollander E: Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 1995;10:11-18.
34. Piccinnelli M, Pini S, Bellantuono C, Wilkinson G: Efficacy of drug treatment in obsessive-compulsive disorder: A meta-analytic review. Br J Psychiatry 1995;166:424-443.
35. Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ: Behavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysis. Psychopharmacology 1998;136:205-216.
36. Maina G, Albert U, Bogetto F: Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-compulsive disorder. Int Clin Psychopharmacol 2001;16:33-38.
37. March JS, Frances A, Carpenter D, Kahn DA (eds): The Expert Consensus Guideline Series: Treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997;58(suppl 4):3-72.
38. McDougle CJ, Goodman W, Leckman JF, Price LH: The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. Psychiatr Clin North Am 1993;16:749-766.
39. Simos G: Medication effects on obsessions and compulsions; in Frost RO, Steketee G (eds): Cognitive Approaches to Obsessions and Compulsions: Theory, Assessment and Treatment. Oxford, Pergamon, 2002.
40. Steketee GS: Treatment of Obsessive-Compulsive Disorder. New York, Guilford, 1993.
41. Kozak MJ, Liebowitz MR, Foa EB: Cognitive behaviour therapy and pharmacotherapy for obsessive-compulsive disorder: The NIMH-sponsored collaborative study; in Goodman WK, Ruderfer MV, Maser JD (eds): Obsessive-Compulsive Disorder: Comtemporary Issues in Treatment. London, Erlbaum, 2000.
42. Cottraux J, Mollard E, Bouvard M, Marks I: Fluvoxamine or combination treatment in obsessive compulsive disorder: One-year follow-up. Psychiatry Res 1993;49:63-75.
43. O'Connor K, Todorov C, Robillard S, Borgeat F, Brault M: Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder: A controlled study. Can J Psychiatry 1999;44:64-71.
44. Greist JH: Treatment of obsessive compulsive disorder: Psychotherapies, drugs and other somatic treatment. J Clin Psychiatry 1990;51:44-50.
45. Black DW, Monahan P, Gable J, Blum N, Clancy G, Baker P: Hoarding and treatment response in 38 nondepressed subjects with OCD. J Clin Psychiatry 1998;59:420-425.
46. Frost RO, Steketee G: Issues in the treatment of compulsive hoarding. Cogn Behav Pract 2000;6:397-407.
47. Clark DA: Cognitive behavioural treatment of obsessive compulsive disorder: A commentary. Cogn Behav Pract 1999;6:408-415.
48. Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L: Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: Results from a controlled trial. Psychother Psychosom 2002;71:255-262.
49. Sookman D, Pinard G: Integrative cognitive therapy for obsessive-compulsive disorder: A focus on multiple schemas. Cogn Behav Pract 1999;6:351-362.
50. Obsessive-Compulsive Cognitions Working Group: Cognitive assessment of obsessive compulsive disorder. Behav Res Ther 1997;35:667-681.
51. Taylor S: Commentary on cognitive approaches to obsessive compulsive disorder: Critical issues and future directions in measurement; in Frost RO, Steketee G (eds): Cognitive Approaches to Obsessions and Compulsions: Theory, Assessment and Treatment. Oxford, Pergamon, 2002.
52. Martin MA: Commentary on cognition in disorders related to obsessive compulsive disorder; in Frost RO, Steketee G (eds): Cognitive Approaches to Obsessions and Compulsions: Theory, Assessment and Treatment. Oxford, Pergamon, 2002.
53. Steketee G, Frost R, Wilson K: Studying cognition in obsessive compulsive disorder: Where to from here?; in Frost RO, Steketee G (eds): Cognitive Approaches to Obsessions and Compulsions: Theory, Assessment and Treatment. Oxford, Pergamon, 2002.
54. Bouvard M: Cognitive effects of cognitive-behaviour therapy for obsessive-compulsive disorder; in Frost RO, Steketee G (eds): Cognitive Approaches to Obsessions and Compulsions: Theory, Assessment and Treatment. Oxford, Pergamon, 2002.
55. Cottraux J: Les ennemis intérieurs: Obsessions et compulsions. Paris, Jacob, 1998.
56. Stanley MA, Turner SM: Current status of pharmacological and behavioural treatment of obsessive compulsive disorder. Behav Ther 1995;26:163-186.